Pra80010 438 445
Pra80010 438 445
W
hen a study outcome is rare in all strata used for an analysis, the odds ratio es-
timate of causal effects will approximate the risk ratio; therefore, odds ratios from
most case-control studies can be interpreted as risk ratios. However, if a study
outcome is common, the odds ratio will be further from 1 than the risk ratio.
There is debate regarding the merits of risk ratios compared with odds ratios for the analysis of
trials and cohort and cross-sectional studies with common outcomes. Odds ratios are conve-
niently symmetrical with regard to the outcome definition; the odds ratio for outcome Y is the in-
verse of the odds ratio for the outcome not Y. Risk ratios lack this symmetry, so it may be neces-
sary to present 1 risk ratio for outcome Y and another for outcome not Y. Risk ratios, but not odds
ratios, have a mathematical property called collapsibility; this means that the size of the risk ratio
will not change if adjustment is made for a variable that is not a confounder. Because of collapsibil-
ity, the risk ratio, assuming no confounding, has a useful interpretation as the ratio change in av-
erage risk due to exposure among the exposed. Because odds ratios are not collapsible, they usu-
ally lack any interpretation either as the change in average odds or the average change in odds (the
average odds ratio). Arch Pediatr Adolesc Med. 2009;163(5):438-445
For more than 20 years, there has been de- risk) of the outcome is A/(A⫹B) among
bate about the relative merits of risk ratios those exposed (Table 1) and C/(C ⫹D)
compared with odds ratios as estimates of among those not exposed; the correspond-
causal associations between an exposure ing odds are A/B and C/D, respectively. The
(such as smoking or medication for high risk ratio is therefore [A/(A ⫹ B)]/[C/
blood pressure) and a binary outcome (such (C ⫹ D)] and the odds ratio is (A/B)/(C/
as death vs life). In this article, I discuss how D). In the literature about these ratios,
these measures differ and review argu- there are 2 areas where there is general
ments for each. To limit my discussion, I agreement: if the outcome is rare, the odds
will ignore other useful measures of asso- ratio will approximate the risk ratio; and
ciation, such as the rate ratio, hazard ratio, in most case-control studies, odds ratios
risk difference, and rate difference. will approximate risk ratios.
In a clinical trial or cohort study in which If the study outcome is rare among those
all subjects are followed up for the same exposed (Table 1), then A will be small
time, the cumulative incidence (average relative to B, so the risk (A/[A⫹B]) will
be close to the odds (A/B). Similarly, if the
Author Affiliations: Department of Epidemiology, School of Public Health and outcome is rare among those not ex-
Community Medicine, and Harborview Injury Prevention and Research Center, posed, then C will be small relative to D
University of Washington, Seattle. and [C/(C⫹ D)] will be close to (C/D). If
(REPRINTED) ARCH PEDIATR ADOLESC MED/ VOL 163 (NO. 5), MAY 2009 WWW.ARCHPEDIATRICS.COM
438
Outcome 5.0
for risk ratios and odds ratios (e, exposed; ne, not exposed; R, individual
risks for outcome = 1): Count A=sum of risks for outcome=1 if 0.5
exposed = sume(Re). Count B=sum of risks for outcome=0 if
exposed = sume(1 − Re). Count C =sum of risks for outcome=1 if not
exposed = sumne(Rne). Count D =sum of risks for outcome=0 if not
exposed = sumne(1 − Rne). Ratio change in cumulative incidence
risk = [A/(A ⫹B)] ÷ [C/(C ⫹D)]=sume (Re)/(A⫹B)÷sumne (Rne)/(C ⫹ D) = sume
(Re)/(A ⫹ B) ÷ sume(Rne)/(A ⫹B)=ratio change in average risk due to exposure
0.1
for the exposed. Average ratio change in risk due to exposure for the
exposed = average risk ratio=sume(Re /Rne)/(A⫹B). Ratio change in
0.1 0.5 1.0 5.0 10.0
cumulative incidence odds=(A/B)÷ (C/D)=sume(Re)/sume(1− Re)÷ sumne(Rne)/
Risk Ratio, Log Scale
sumne(1 − Rne) = sume (Re)/sume(1− Re)÷sume(Rne)/sume(1− Rne). Ratio change
in average odds due to exposure for the exposed=sume [Re /(1− Re)]/(A ⫹ B)
÷ sume [Rne /(1 −Rne)]/(A ⫹ B). Average ratio change in odds due to exposure Figure 1. Relationship of the odds ratio to the risk ratio according to 4 levels
for the exposed = average odds ratio=sume([Re /(1− Re)]÷ [Rne /(1− Rne)]). of outcome risk (cumulative incidence) for unexposed subjects: .01, .10, .25,
and .50.
(REPRINTED) ARCH PEDIATR ADOLESC MED/ VOL 163 (NO. 5), MAY 2009 WWW.ARCHPEDIATRICS.COM
439
5.0
Vehicle Outcome, No.
Crash Seat Belt Risk Odds
Speed Used Died Survived Risk Ratio Odds Ratio
Odds Ratio, Log Scale
0.1
Some argue that risk ratios should be preferred because
.01 .10 .25 .50 they are more easily understood by clinicians.6,7 How-
0.1 0.5 1.0 5.0 10.0 ever, if odds ratios were otherwise superior, a better so-
Risk Ratio, Log Scale lution might be to use odds ratios and remedy any defi-
ciency in clinician education.
Figure 3. Relationship of the odds ratio to the risk ratio according to 4 levels
of outcome risk (cumulative incidence) for an average exposed and Symmetry of Odds Ratios Regarding
unexposed subject: .01, .10, .25, and .50. Estimates assume the number of Outcome Definitions
exposed subjects is equal to the number unexposed.
(REPRINTED) ARCH PEDIATR ADOLESC MED/ VOL 163 (NO. 5), MAY 2009 WWW.ARCHPEDIATRICS.COM
440
Rebuttals to Odds Ratio Constancy Argument Lack of Collapsibility−A Barrier to Estimating Odds Ra-
tios That Can Be Interpreted as Averages. It has been
Possibility of Constancy for Risk Ratios Less Than 1. known for years that risk ratios are collapsible while odds
For both risk and odds, the lower limit is 0. For any level ratios are not,1,11,16-18 but this is not mentioned in much
of risk or odds under no exposure, multiplication by a of the literature about these ratios. Some readers may find
risk or odds ratio less than 1 will produce a risk or odds this topic unfamiliar, technical, and even counterintui-
given exposure that is possible: 0 to 1 for risks and 0 to tive. To simplify my discussion, I will assume that there
infinity for odds. Thus, a constant risk or odds ratio is is no bias due to confounding. Had exposure not oc-
possible for ratios less than 1. If the risk ratio compar- curred, the average risk for the outcome would have been
ing exposed persons with those not exposed is greater the same in the exposed group as in the unexposed group.
than 1, the ratio can be inverted to be less than 1 by com- Collapsibility means that in the absence of confound-
paring persons not exposed with those exposed. There- ing, a weighted average of stratum-specific ratios (eg, using
fore, a constant risk ratio less than 1 is hypothetically pos- Mantel-Haenszel methods19) will equal the ratio from a
sible. This argument has been used to rebut the criticism single 2⫻ 2 table of the pooled (collapsed) counts from
of the risk ratio in the previous argument.15 the stratum-specific tables. This means that a crude (un-
adjusted) ratio will not change if we adjust for a variable
Constancy of Risk or Odds Ratios Not Necessary for that is not a confounder.18,20
Inference. It is not necessary that the risk or odds ratio I created hypothetical data for 2 randomized con-
be constant. We can use a ratio to make causal infer- trolled trials (Table 4 and Table 5). In both trials, the
ences or decisions about public and personal health if risk for the outcome, aside from exposure to treatment,
the ratio has an interpretation as an average effect: falls into just 2 categories. There is no confounding, as
either (1) the ratio change in average risk or odds or (2) the average risk without exposure is the same in each trial
the average ratio change in risk or odds. The ratio arm. Individual risks without exposure would not be
change in average risk (or odds) is not the same as the known in an actual trial; if they were knowable, we would
average ratio change in risk (or odds) (Table 1). not need a control group. The key difference between the
An estimate of the change in average risk is useful, tables is that the risk ratio is constant for all persons in
though it may not estimate the change expected for ev- Table 4, whereas the odds ratio is constant in Table 5.
ery individual or even for any particular individual. For In Table 4, the risk ratio due to exposure is 3.00 for
example, if research suggests that wearing a seat belt in all exposed persons, regardless of outcome risk (.05 or
a crash reduces the average risk of death by 50%, people .25) if not exposed. In a real trial, we could observe only
could use this information to make a decision about seat the data in the last column, where the risk ratio is 3.00
belt use, although this estimate might not apply to them for males, females, and all persons. The risk ratio of 3.00
in a given crash. If we had evidence that the average ra- for all persons has 3 interpretations1: (1) the ratio change
tio change in risk varied with levels of another factor, say in risk due to exposure for the exposed group, (2) the
age, the best choice might be to estimate several risk ra- ratio change in the average risk due to exposure among
(REPRINTED) ARCH PEDIATR ADOLESC MED/ VOL 163 (NO. 5), MAY 2009 WWW.ARCHPEDIATRICS.COM
441
Y No Y Y No Y Y No Y
Males
Treatment X, No.
Yes 15 85 225 75 240 160
No 5 95 75 225 80 320
Risk ratio 3.00 3.00 3.00
Odds ratio 3.35 9.00 6.00
Females
Treatment X, No.
Yes 45 255 75 25 120 280
No 15 285 25 75 40 360
Risk ratio 3.00 3.00 3.00
Odds ratio 3.35 9.00 3.86
All Persons
Treatment X, No.
Yes 60 340 300 100 360 440
No 20 380 100 300 120 680
Risk ratio 3.00 3.00 3.00
Odds ratio 3.35 9.00 4.64
a The risk for outcome Y, aside from exposure, is either low (.05) or high (.25). In this table, risk ratios are the same for all subjects. Ratio change in average
risk due to exposure among the exposed=([.05 ⫻(15 ⫹85 ⫹ 45 ⫹ 255)⫻ 3.00]⫹ [.25⫻ (225⫹ 75⫹ 75⫹ 25)⫻ 3.00]) ÷ ([.05⫻ (15⫹ 85⫹ 45⫹ 255)]⫹[.25⫻
(225 ⫹ 75 ⫹ 75 ⫹25)])=3.00. Average ratio change in risk for all exposed individuals (average risk ratio) = ([3.00 ⫻ (15⫹ 85)]⫹ [3.00⫻ (225⫹ 75)]⫹ [3.00 ⫻
(45 ⫹ 255)] ⫹ [3.00 ⫻ (75⫹ 25)])÷(15⫹ 85⫹ 225⫹75 ⫹ 45 ⫹255 ⫹ 75⫹ 25) = 3.00. Ratio change in average odds due to exposure among the
exposed = ([(.05/.95) ⫻(15 ⫹85 ⫹45 ⫹255)⫻ 3.35] ⫹[(.25/.75)⫻ (225⫹ 75⫹ 75 ⫹ 25)⫻ 9.00]) ÷ ([(.05/.95) ⫻ (15⫹ 85⫹ 45⫹ 255)]⫹
[(.25/.75) ⫻ (225 ⫹ 75 ⫹75⫹ 25)])=8.23. Average ratio change in odds for all exposed individuals (average odds ratio) = ([3.35 ⫻ (15⫹ 85)]⫹ [9.00⫻ (225⫹75)]
⫹ [3.35 ⫻(45 ⫹255)] ⫹[9.00⫻ (75⫹25)])÷(15 ⫹85 ⫹ 225⫹75 ⫹ 45⫹ 255⫹ 75⫹ 25) = 6.18.
Y2 No Y2 Y2 No Y2 Y2 No Y2
Males
Treatment X2, No.
Yes 51 51 288 18 339 69
No 20 80 240 60 260 140
Risk ratio 2.50 1.18 1.28
Odds ratio 4.00 4.00 2.65
Females
Treatment X2, No.
Yes 153 153 96 6 249 159
No 60 240 80 20 140 260
Risk ratio 2.50 1.18 1.74
Odds ratio 4.00 4.00 2.91
All Persons
Treatment X2, No.
Yes 204 204 384 24 588 228
No 80 320 320 80 400 400
Risk ratio 2.50 1.18 1.44
Odds ratio 4.00 4.00 2.58
a The risk for outcome Y2, aside from exposure, is either low (.2) or high (.8). In this table, the odds ratio is the same for all subjects. Ratio change in average
risk due to exposure among the exposed=([.2 ⫻(51 ⫹51 ⫹153 ⫹ 153)⫻ 2.50]⫹ [.8⫻ (288⫹ 18 ⫹ 96⫹ 6)⫻ 1.18]) ÷ ([.2⫻ (51⫹ 51⫹ 153⫹ 153)]⫹ [.8⫻
(288 ⫹ 18 ⫹ 96 ⫹6)])=1.44. Average ratio change in risk for all exposed individuals (average risk ratio) = ([2.50 ⫻ (51⫹ 51)]⫹ [1.18⫻ (288⫹ 18)]⫹ [2.50⫻
(153 ⫹ 153)] ⫹ [1.18 ⫻(96 ⫹6)])÷(51 ⫹ 51⫹ 288⫹18 ⫹ 153⫹153⫹ 96⫹ 6) = 1.84. Ratio change in average odds due to exposure among the
exposed = ([(.2/.8) ⫻ (51⫹ 51 ⫹153⫹ 153) ⫻4.00]⫹[(.8/.2)⫻(288⫹ 18⫹ 96⫹ 6)⫻ 4.00]) ÷ [(.2/.8)⫻ (51⫹ 51⫹ 153⫹ 153)⫹ (.8/.2)⫻
(288 ⫹ 18 ⫹96 ⫹ 6)] =4.00. Average ratio change in odds for all exposed individuals (average odds ratio) = ([4.00 ⫻ (51⫹ 51)]⫹ [4.00⫻ (288⫹ 18)]⫹ [4.00 ⫻
(153 ⫹ 153)] ⫹ [4.00⫻ (96⫹ 6)])÷(51 ⫹ 51⫹ 288⫹ 18 ⫹153⫹ 153⫹ 96 ⫹ 6) = 4.00.
the exposed, and (3) the average ratio change in risk for The risk ratios in Table 4 are collapsible. Any weighted
all exposed individuals (ie, the average risk ratio) average of the constant risk ratio of 3.00 should be 3.00;
(Table 1). in Table 4, all 5 collapsed tables do indeed yield risk ra-
(REPRINTED) ARCH PEDIATR ADOLESC MED/ VOL 163 (NO. 5), MAY 2009 WWW.ARCHPEDIATRICS.COM
442
(REPRINTED) ARCH PEDIATR ADOLESC MED/ VOL 163 (NO. 5), MAY 2009 WWW.ARCHPEDIATRICS.COM
443
(REPRINTED) ARCH PEDIATR ADOLESC MED/ VOL 163 (NO. 5), MAY 2009 WWW.ARCHPEDIATRICS.COM
444
(REPRINTED) ARCH PEDIATR ADOLESC MED/ VOL 163 (NO. 5), MAY 2009 WWW.ARCHPEDIATRICS.COM
445